Cooper Companies (COO) Other Non-Current Liabilities (2010 - 2026)
Cooper Companies (COO) posted Other Non-Current Liabilities of $266.4 million for Q2 2026, down 3.9% on a QoQ basis from $277.2 million in Q1 2026, and down 2.84% year-over-year from $274.2 million in Q2 2025.
Analysis
Cooper Companies (COO) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
Cooper Companies has reported Other Non-Current Liabilities for 11 years, with the latest figure at $266.4 million in Q2 2026.
- On a quarterly basis, Other Non-Current Liabilities fell 2.84% year-over-year to $266.4 million in Q2 2026; TTM through Apr 2026 was $266.4 million, a 2.84% decrease from a year earlier, with the FY2025 full-year figure at $282.8 million, down 9.24% from the prior year.
- Other Non-Current Liabilities was $266.4 million for Q2 2026 at Cooper Companies, down from $277.2 million in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $311.6 million in Q4 2024, with the low at $90.5 million in Q3 2023.
- Average Other Non-Current Liabilities over 5 years is $217.3 million, with a median of $262.1 million recorded in 2025.
- The sharpest annual moves came in 2022 and 2023: Other Non-Current Liabilities surged 309.42% in 2022, then dropped 28.07% in 2023.
- Over 5 years, Other Non-Current Liabilities stood at $225.2 million in 2022, then grew by 6.22% to $239.2 million in 2023, then jumped by 30.27% to $311.6 million in 2024, then retreated by 9.24% to $282.8 million in 2025, then decreased by 5.8% to $266.4 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $266.4 million (Q2 2026), $277.2 million (Q1 2026), and $282.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn |
| 10 | Cooper Companies | 10.51 Bn | 10.37 Bn | 735.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 266.40 Mn |
| Jan 31, 2026 | 277.20 Mn |
| Oct 31, 2025 | 282.80 Mn |
| Jul 31, 2025 | 263.20 Mn |
| Apr 30, 2025 | 274.20 Mn |
| Jan 31, 2025 | 261.00 Mn |
| Oct 31, 2024 | 311.60 Mn |
| Jul 31, 2024 | 277.00 Mn |
| Apr 30, 2024 | 277.90 Mn |
| Jan 31, 2024 | 281.40 Mn |
| Oct 31, 2023 | 239.20 Mn |
| Jul 31, 2023 | 90.50 Mn |
| Apr 30, 2023 | 90.70 Mn |
| Jan 31, 2023 | 112.40 Mn |
| Oct 31, 2022 | 225.20 Mn |
| Jul 31, 2022 | 116.80 Mn |
| Apr 30, 2022 | 126.10 Mn |
| Jan 31, 2022 | 138.00 Mn |
| Oct 31, 2021 | 139.60 Mn |
| Jul 31, 2021 | 139.60 Mn |